Product NDC: | 42291-241 |
Proprietary Name: | Desmopressin Acetate |
Non Proprietary Name: | Desmopressin Acetate |
Active Ingredient(s): | .1 mg/1 & nbsp; Desmopressin Acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42291-241 |
Labeler Name: | AvKARE, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076470 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130307 |
Package NDC: | 42291-241-90 |
Package Description: | 90 TABLET in 1 BOTTLE (42291-241-90) |
NDC Code | 42291-241-90 |
Proprietary Name | Desmopressin Acetate |
Package Description | 90 TABLET in 1 BOTTLE (42291-241-90) |
Product NDC | 42291-241 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desmopressin Acetate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130307 |
Marketing Category Name | ANDA |
Labeler Name | AvKARE, Inc. |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | .1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |